NEW YORK (GenomeWeb News) – Agilent Technologies and Applied Proteomics today announced a collaboration to develop multiplex protein assays and workflow solutions for multiple reaction monitoring (MRM) using mass spectrometry.

Applied Proteomics will use Agilent instruments, including the 6490 Triple Quadrupole MS/MS, 1290 Infinity LC, RapidFire 360 MS system, and Bravo liquid handling technologies to "optimize the throughput of highly multiplexed proteomic assays," the firms said.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.